Vinnova has granted Gedea Biotech's application for innovative startup companies. The applications were reviewed by external assessors and Gedea Biotech was one of the selected among over 650 applicants. Gedea Biotech develops a novel treatment of vaginal candida infections. In the project a prototype of the vaginal tablet will be formulated. Read more